About
Biomarker-based cancer drugs
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
154
By Phase
PHASE1: 2
By Status
RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05872867Lead Sponsor
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)
PHASE1Recruiting
54 participants
Started: Mar 14, 2024 · Completed: Feb 22, 2026
NCT04801095Lead Sponsor
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
PHASE1Unknown
100 participants
Started: Jul 14, 2021 · Completed: Aug 8, 2025
Locations (1)
Headquarters
Hanam, Korea
Map
Loading map...